A detailed history of Goepper Burkhardt LLC transactions in Novartis Ag stock. As of the latest transaction made, Goepper Burkhardt LLC holds 1,950 shares of NVS stock, worth $203,346. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,950
Previous 1,950 -0.0%
Holding current value
$203,346
Previous $207,000 8.21%
% of portfolio
0.09%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $180,511 - $209,371
1,950 New
1,950 $207,000
Q3 2023

Nov 13, 2023

BUY
$94.73 - $105.13 $186,618 - $207,106
1,970 New
1,970 $200,000
Q4 2022

Feb 15, 2023

BUY
$75.55 - $92.52 $169,987 - $208,170
2,250 New
2,250 $204,000
Q4 2021

Jan 21, 2022

SELL
$79.7 - $88.13 $195,265 - $215,918
-2,450 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$78.07 - $94.43 $191,271 - $231,353
2,450 New
2,450 $231,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Goepper Burkhardt LLC Portfolio

Follow Goepper Burkhardt LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goepper Burkhardt LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goepper Burkhardt LLC with notifications on news.